News

Hosted on MSN4mon
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to ... neuroscience leader with the drug’s manufacturer, Johnson & Johnson, said in a news release.
Hosted on MSN1mon
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (WPIX) – The U.S ... The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson ...
Business Insider4y
Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential
Called Spravato, a brand name for esketamine, and developed by Johnson & Johnson, the drug is a nasal spray designed ... Administration (FDA) approved Johnson & Johnson's new drug, which is ...
pharmaphorum7d
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...